Business Results for Fiscal 2022 and Earnings Forecast for Fiscal 2023
Outlook for China Business
2
Business Results for Fiscal 2022 and Earnings Forecast for Fiscal 2023
Director, and CFO
Muneki Handa
Agenda
01
FY 2022 Business Results Overview
4
Roadmap for the Realization of the TSUMURA VISION
"Cho-WA" 2031
1st stage
FY2022-2024
-Germination-
2nd stage
FY2025-2027
-Growth-
3rd stage
FY2028-2031
-Flowering-
Prescription Kampo
Products
Standardization of Kampo treatments
Personalized Kampo treatments
Over 50% physicians write 10 or more Kampo prescriptions
50% of physicians write basic
prescriptions in all treatment areas
R&D
Personalized Kampo
treatmentsResearch Scientific study of pre-
symptomatic diseases
Development
Social
implementation
Formulation
platform
China
Crude drug
Business
platform
Research
platform
Traditional Chinese medical products business
Crude drugs, drug pieces and Yakushokudogen products
Traditional Chinese Medicine Research Center
Market
entry
Sales
expansion
Establishment
Build
foundations
Establish brands
Function
expansion
Establish brands
Lead industry development
Evidence-building for traditional
Chinese medical products
Smart factory
Expand scope of
automation
Shift to oversight/management
Realize smart factories
Labor
productivity
Sales
Production
Crude drugs
Sales per MR (Yen/MR)
Physical labor productivity
Personnel expenses per crude drug arranging volume
Double productivity
(vs. FY2021)
5
Attachments
Original Link
Original Document
Permalink
Disclaimer
Tsumura & Co. published this content on 16 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 May 2023 08:49:09 UTC.
TSUMURA & CO. is a Japan-based company mainly engaged in the manufacture and sale of ethical and general pharmaceuticals. Through its subsidiaries, the Company is also engaged in the procurement, sorting and processing of crude drugs, the manufacture and sale of Chinese herbal extract powders and drug substances, the operation of dispensing pharmacies and the provision of logistics services, as well as the development of pharmaceuticals.
TSUMURA & CO. 
